Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 222,708,794 papers from all fields of science
Search
Sign In
Create Free Account
TAC 278
Known as:
5-Pyrimidinecarboxylic acid, 4-butoxy-5-fluorohexahydro-2,6-dioxo-, ethyl ester
, TAC-278
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (1)
Fluorouracil
analogs & derivatives
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Studies on the designing of chemotherapy for gastric cancer in man, based on the tumor tissue concentration of anticancer agents
S. Suga
,
K. Kimura
,
+6 authors
H. Iwase
Gastroenterologia Japonica
2007
Corpus ID: 5949368
Summary5-fluorouracil analogs investigated in this study include a combination of uracil and Ftorafur (UFT), Ethyl (±)-t-butoxy-5…
Expand
1983
1983
[Cerebrospinal fluid distributions of systemically administered fluorinated pyrimidines].
K. Sueyoshi
,
H. Majima
Gan to kagaku ryoho. Cancer & chemotherapy
1983
Corpus ID: 39441639
Transfer of systemically administered fluorinated pyrimidines (Tegafur, TAC-278, HCFU and FD-1) to cerebrospinal fluid was…
Expand
1982
1982
[Pharmacological and pharmacodynamic aspects of cancer chemotherapy, with special reference to 5-fluorouracil and its derivatives].
K. Kimura
,
S. Suga
Gan to kagaku ryoho. Cancer & chemotherapy
1982
Corpus ID: 11422583
5-FU analogs being investigated in Japan are; 5-FU, FT, FD-1, HCFU, UFT, TAC-278, 5'-DFUR, FF-705, and TK-117. They exert…
Expand
1982
1982
[Phase I clinical study of a new fluorinated pyrimidine antineoplastic agent, TAC-278].
Y. Koyama
Gan to kagaku ryoho. Cancer & chemotherapy
1982
Corpus ID: 33481808
A new fluorinated pyrimidine, TAC-278, was studied for its safety, anti-tumor activity and pharmacokinetics in patients with…
Expand
1982
1982
[TAC-278. A new 5-FU derivative, by the oral route for its efficacy and safety in 36 patients with advanced cancers].
K. Watanabe
,
H. Satoh
,
+7 authors
S. Yamamoto
Gan to kagaku ryoho. Cancer & chemotherapy
1982
Corpus ID: 2572734
Tumor regression was observed in only one patient. Twelve (33%) of the 36 patients reported adverse effects: gastrointestinal…
Expand
1982
1982
[Phase II study of a new fluorinated pyrimidine, ethyl (+/-)-t-6-butoxy-5-fluoro-2, 4-dioxohexahydropyrimidine-r-5-carboxylate (TAC-278)].
Gan to kagaku ryoho. Cancer & chemotherapy
1982
Corpus ID: 42765459
A Phase II study of a new fluorinated pyrimidine (TAC-278) was performed in 14 institutions from May 1980 to April 1981. 400-1200…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE